What is Nubeqa for Prostate Cancer and How Does it Work? | Ask a Prostate Expert, Mark Scholz, MD

PCRI's, Alex asks Mark Scholz, MD, about Nubeqa (generic name: darolutamide), the newest second-generation hormonal agent to be FDA approved.

0:06 What is Nubeqa?

1:40 How does Nubeqa work?

2:35 Does Nubeqa actually delay cancer progression 3.3 years?

3:47 Have you given a patient Nubeqa before?

4:02 What are Nubeqa's side effects like?

4:23 What effect do you think Nubeqa will have on prostate cancer treatment going forward?

Don’t know your prostate cancer stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org

To download the free Staging Guide visit http://www.pcri.org/prostate-cancer-s...

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD